Search

Author/Creator Koh, Liang Piu

1. Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore's private insurance payer's perspective. (1st January 2021)

Authors:
Wang, Xiao Jun; Wang, Yi-Ho; Li, Shing Chau Tony; Gkitzia, Christina; Lim, Soon Thye; Koh, Liang Piu; Lim, Francesca Lorraine Wei Inng; Hwang, William Ying Khee
Journal:
Journal of medical economics
Issue:
Volume 24:Number 1(2021)
Page Start:
637
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia. Issue 7 (23rd March 2016)

Authors:
Yan, Benedict; Ng, Christopher; Moshi, Grace; Ban, Kenneth; Lee, Peak-Ling; Seah, Elaine; Chiu, Lily; Koay, Evelyn S C; Liu, Te-Chih; Ng, Chin Hin; Chng, Wee-Joo; Koh, Liang Piu
Journal:
Journal of clinical pathology
Issue:
Volume 69:Issue 7(2016)
Page Start:
652
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Necrotizing Fasciitis in Hematological Patients: Enterobacteriaceae Predominance and Limited Utility of Laboratory Risk Indicator for Necrotizing Fasciitis Score. (12th June 2015)

Authors:
Foo, Rui Min; Tung, Moon Ley; Poon, Li Mei; Chan, Douglas; Smitasin, Nares; Koh, Liang Piu; Chng, Wee Joo; Chai, Louis Yi Ann
Journal:
Open forum infectious diseases
Issue:
Volume 2:Number 2(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Rapid production of clinical‐grade SARS‐CoV‐2 specific T cells. Issue 4 (31st July 2020)

Authors:
Leung, Wing; Soh, Teck Guan; Linn, Yeh Ching; Low, Jenny Guek‐Hong; Loh, Jiashen; Chan, Marieta; Chng, Wee Joo; Koh, Liang Piu; Poon, Michelle Li‐Mei; Ng, King Pan; Kuick, Chik Hong; Tan, Thuan Tong; Tan, Lip Kun; Seng, Michaela Su‐fern
Journal:
Advances in cell and gene therapy
Issue:
Volume 3:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma. (2nd July 2019)

Authors:
Chan, Esther Hian Li; Koh, Liang Piu; Lee, Joanne; De Mel, Sanjay; Jeyasekharan, Anand; Liu, Xin; Tang, Tiffany; Lim, Soon Thye; Tao, Miriam; Quek, Richard; Farid Bin Harunal Ras, Mohamad; Lee, Yuh Shan; Diong, Colin; Tan, Daryl; Kim, Seok Jin; Chee, Yen Lin; Poon, Li Mei Michelle
Journal:
Cancer medicine
Issue:
Volume 8:Number 10(2019:Aug.)
Page Start:
4626
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis. (30th July 2021)

Authors:
Pardanani, Animesh; Tefferi, Ayalew; Masszi, Tamás; Mishchenko, Elena; Drummond, Mark; Jourdan, Eric; Vannucchi, Alessandro; Jurgutis, Mindaugas; Ribrag, Vincent; Rambaldi, Alessandro; Koh, Liang Piu; Rose, Shelonitda; Zhang, Jun; Harrison, Claire
Journal:
British journal of haematology
Issue:
Volume 195:Number 2(2021)
Page Start:
244
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗